Luteolin: How To Reduce Breast Cancer Risk

More than 100 women die of breast cancer in the U.S. every day. It's the second leading cause of cancer deaths in American women. But in my opinion, many of those women really die of a tragic medical error. Let me explain… Millions of women in the U.S. have taken Big Pharma's hormone replacement therapy (HRT). Their doctors prescribe it to try to relieve the symptoms of menopause. Like hot flashes, night sweats, mood swings and weight gain. But what the drug companies try to pass off as hormones are actually synthetic concoctions. They are fake versions of the estrogen and progesterone that your body makes naturally. In other words, they are drugs. And they are dangerous. Big Pharma's fake progesterone is called "progestin." Studies show progestin increases the blood vessels that fuel tumor growth. It also increases cell proliferation. It stimulates metastasis to the lymph nodes. And it boosts the number of cancer stem cells that don't respond to cancer treatments. And here's what's really tragic… Many doctors don't realize that most older women have benign growths in their breast tissue. It's normal. But these growths don't form tumors until they receive a trigger that attracts blood vessels to feed them. That trigger is progestin. The famous Women's Health Initiative study in 2002 proved it. Women who take progestin have much higher rates of breast cancer. They also have much higher rates of heart disease, st...
Source: Al Sears, MD Natural Remedies - Category: Complementary Medicine Authors: Tags: Anti-Aging Source Type: news

Related Links:

In this study, we use ChIP-Seq to identify Dppa4 binding genome-wide in three distinct cell types: mouse embryonic stem cells (mESC), embryonal carcinoma cells, and 3T3 fibroblasts ectopically expressing Dppa4. We find a core set of Dppa4 binding sites shared across cell types, and also a substantial number of sites unique to each cell type. Across cell types Dppa4 shows a preference for binding to regions with active chromatin signatures, and can influence chromatin modifications at target genes. In 3T3 fibroblasts with enforced Dppa4 expression, Dppa4 represses the cell cycle inhibitor Cdkn2c and activates Ets family tra...
Source: Stem Cell Research - Category: Stem Cells Source Type: research
Publication date: Available online 19 July 2018Source: Stem Cell ResearchAuthor(s): Stephanie N. Iwasa, Milos R. Popovic, Cindi M. MorsheadAbstractMany cell types respond to electric fields (EFs) through cell migration, a process termed galvanotaxis. The galvanotactic response is critical for development and wound healing. Here we investigated whether skin-derived precursor cells (SKPs), which have the potential to differentiate into mesodermal and peripheral neural cell types, undergo directed migration in the presence of an EF. We found that EF application promotes SKP migration towards the anode. The migratory response ...
Source: Stem Cell Research - Category: Stem Cells Source Type: research
Conclusions: LUCAT1 was upregulated in ccRCC tissues and renal cancer cell lines, and significantly correlated with malignant stage and poor prognosis in ccRCC. LUCAT1 promoted proliferation and invasion in ccRCC cells through the AKT/GSK-3 β signaling pathway. We also revealed that LUCAT1 overexpression was induced by chemokine CXCL2. These findings indicate that the CXCL2/LUCAT1/AKT/GSK-3β axis is a potential therapeutic target and molecular biomarker for ccRCC.Cell Physiol Biochem 2018;48:891 –904
Source: Cellular Physiology and Biochemistry - Category: Cytology Source Type: research
Conclusion: Impaired osteogenesis is linked to mutantMAPK7-induced idiopathic scoliosis , and RPS6KA3 may play an important role in this process.Cell Physiol Biochem 2018;48:880 –890
Source: Cellular Physiology and Biochemistry - Category: Cytology Source Type: research
Conclusion: Our results have revealed a novel mechanism by which ALKBH5 inhibits pancreatic cancer motility by demethylating lncRNA KCNK15-AS1, identifying a potential therapeutic target for pancreatic cancer.Cell Physiol Biochem 2018;48:838 –846
Source: Cellular Physiology and Biochemistry - Category: Cytology Source Type: research
Conclusion: Lower expression of miR-374a is associated with poor prognosis and miR-374a improves tumor biological behavior in bladder cancer cells, suggesting that miR-374a might be a novel small-molecule therapeutic target.Cell Physiol Biochem 2018;48:815 –826
Source: Cellular Physiology and Biochemistry - Category: Cytology Source Type: research
Conclusions: Our data revealbiological and functional interactions between immunotherapy and radiotherapy through the miR-195/-16 family regulatory cascade.Cell Physiol Biochem 2018;48:801 –814
Source: Cellular Physiology and Biochemistry - Category: Cytology Source Type: research
Publication date: November 2018Source: Clinica Chimica Acta, Volume 486Author(s): Jieli Li, Jing Ma, Elizabeth A. Wagar, Dong Liang, Qing H. MengAbstractBackgroundVoriconazole (VOR), an antifungal agent, is clinically monitored to guide therapeutic dosing and avoid toxicity. It is believed that measurement of serum unbound VOR provides more accurate information, especially in hypoalbuminemia patients. We developed and validated an accurate, simple and fast test with ultrafiltration and ultra-performance liquid chromatography (UPLC)-tandem mass spectrometry (MS/MS) to measure unbound VOR in human serum.MethodsThe Agilent UP...
Source: Clinica Chimica Acta - Category: Laboratory Medicine Source Type: research
Conclusions: The current findings indicate that MST1 participates in SAH-induced BBB disruption and white matter fiber damage via the downstream NF-κB-MMP-9 signaling pathway. Therefore, MST1 antagonists may serve as a novel therapeutic target to prevent early brain injury in SAH patients. PMID: 30018671 [PubMed - in process]
Source: Behavioural Neurology - Category: Neurology Authors: Tags: Behav Neurol Source Type: research
Abstract Aberrant production of nitric oxide following inducible nitric oxide synthase (iNOS) expression has been implicated in cell death and contributes to ischemic brain injury. Tetrahydrobiopterin (BH4) is an essential cofactor of NOS activity. Herein, we evaluated antiapoptotic and anti-inflammatory effects of diamino-6-hydroxypyrimidine (DAHP), a guanosine 5'-triphosphate cyclohydrolase 1 (GTPCH1) inhibitor on focal cerebral ischemia-reperfusion injury by middle cerebral artery occlusion and reperfusion (MCAO) and investigated the underlying mechanism. Sprague-Dawley rats were divided into five groups. Exper...
Source: Behavioural Neurology - Category: Neurology Authors: Tags: Behav Neurol Source Type: research
More News: Artichokes | Breast Cancer | Brussels Sprouts | Cancer | Cancer & Oncology | Cardiology | Chemistry | Colon Cancer | Colorectal Cancer | Complementary Medicine | Family Practices | Heart | Heart Disease | Herbs | Hormonal Therapy | Hormone Replacement Therapy | Hormones | Juniper | Lemon Fruit | Leukemia | Malpractice | Men | Menopause | Nutrition | Oregano | Peppermint | Pharmaceuticals | Propolis | Prostate Cancer | Spinach | Stem Cell Therapy | Stem Cells | Stroke | Study | Thyme | Thyroid | Thyroid Cancer | Toxicology | Women